News stories about Maximus (NYSE:MMS) have been trending somewhat positive on Friday, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Maximus earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave media coverage about the health services provider an impact score of 45.8866553972658 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:

Several brokerages have issued reports on MMS. Zacks Investment Research raised shares of Maximus from a “hold” rating to a “buy” rating and set a $73.00 price objective for the company in a research note on Wednesday, October 4th. BidaskClub downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Maxim Group set a $66.00 price objective on shares of Maximus and gave the stock a “hold” rating in a research note on Thursday, August 3rd. Finally, Robert W. Baird began coverage on shares of Maximus in a research note on Sunday, September 3rd. They issued a “neutral” rating for the company. One analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company’s stock. Maximus presently has an average rating of “Hold” and a consensus price target of $63.14.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, topping the consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The firm had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. During the same period in the prior year, the business posted $0.79 EPS. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be issued a $0.045 dividend. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. Maximus’s dividend payout ratio is currently 5.73%.

In other news, President Bruce Caswell sold 8,000 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $59.83, for a total value of $478,640.00. Following the transaction, the president now directly owns 35,904 shares in the company, valued at approximately $2,148,136.32. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Richard A. Montoni sold 29,203 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the transaction, the chief executive officer now owns 549,215 shares in the company, valued at $33,161,601.70. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 143,403 shares of company stock worth $8,866,281. Company insiders own 3.10% of the company’s stock.

WARNING: “Maximus (MMS) Getting Somewhat Positive Press Coverage, Study Shows” was originally published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/maximus-mms-getting-somewhat-positive-press-coverage-study-shows/1674948.html.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.